189 related articles for article (PubMed ID: 33934537)
21. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
23. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
24. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
25. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Castanon A; Landy R; Sasieni PD
Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
[TBL] [Abstract][Full Text] [Related]
26. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
[TBL] [Abstract][Full Text] [Related]
28. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
29. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
30. Cytomorphologic Features of Gastric-Type Endocervical Adenocarcinoma in Liquid-Based Preparations.
Schwock J; Starova B; Khan ZF; Mirkovic J; Parra-Herran C; Ko HM; Rouzbahman M; Ghorab Z
Acta Cytol; 2021; 65(1):56-66. PubMed ID: 33152741
[TBL] [Abstract][Full Text] [Related]
31. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
32. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
33. Present standards for cervical cancer screening.
O'Meara AT
Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
[TBL] [Abstract][Full Text] [Related]
34. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
35. Cervical cytology reproducibility and associated clinical and demographic factors.
Hwang H; Follen M; Guillaud M; Scheurer M; MacAulay C; MacAulay C; Staerkel GA; van Niekerk D; Yamal JM
Diagn Cytopathol; 2020 Jan; 48(1):35-42. PubMed ID: 31639288
[TBL] [Abstract][Full Text] [Related]
36. How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
Mehta SP; Patel TS; Jana T; Samanta ST; Malvania R; Trivedi PP; Girdher S
Diagn Cytopathol; 2021 Jan; 49(1):127-131. PubMed ID: 32910561
[TBL] [Abstract][Full Text] [Related]
37. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
38. Clinical results of a split sample liquid-based cytology (ThinPrep) study of 4,322 patients in a Turkish institution.
Tuncer ZS; Başaran M; Sezgin Y; Firat P; Mocan Kuzey G
Eur J Gynaecol Oncol; 2005; 26(6):646-8. PubMed ID: 16398228
[TBL] [Abstract][Full Text] [Related]
39. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
40. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
